Suppr超能文献

血管紧张素轴拮抗剂会增加二氢吡啶类钙通道阻滞剂中毒患者发生血流动力学不稳定的风险。

Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning.

机构信息

Faculty of Medicine, University of New South Wales, Sydney, Australia.

Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

出版信息

Clin Toxicol (Phila). 2021 Jun;59(6):464-471. doi: 10.1080/15563650.2020.1826504. Epub 2020 Oct 6.

Abstract

CONTEXT

Amlodipine, a dihydropyridine calcium channel blocker (CCB), is the leading cause of cardiovascular drug-related overdose deaths in the USA. In contrast, angiotensin-II receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) cause minimal toxicity in overdose. ACEIs/ARBs are often combined with dihydropyridines in hypertension treatment. Co-ingested ARBs/ACEIs may significantly contribute to the toxicity of dihydropyridine, but this has not been investigated.

OBJECTIVE

To investigate the clinical outcomes from dihydropyridine overdoses with ARBs/ACEIs versus dihydropyridine overdoses alone.

METHODS

This was a retrospective study of patients reported to the New South Wales Poisons Information Centre (NSW PIC) and 3 toxicology units (Jan 2016 to Jun 2019) in Australia. Patients >14 years who took an overdose of dihydropyridines (amlodipine, felodipine, lercanidipine, nifedipine) were included. Concurrent overdoses with non-dihydropyridine CCBs, alpha-blockers and beta-blockers were excluded. Patient demographics, drugs exposure details, serial vital signs, treatments and outcome were collected.

RESULTS

There were 100 patients. 68 took mixed overdoses of dihydropyridines with ARBs/ACEIs and 32 took single overdoses of dihydropyridines without ARBs/ACEIs. The mixed group had lower median nadir mean arterial pressures (62 vs 75 mmHg,  < 0.001), more frequently had hypotension (OR 4.5, 95%CI: 1.7-11.9) or bradycardia (OR 8.8, 95%CI: 1.1-70). Multivariable analysis indicated the mixed overdoses had an 11.5 mmHg (95%CI: 4.9-18.1) lower minimum systolic blood pressure (SBP) compared with the single group; other factors associated with a lower minimum SBP were higher doses [2.3 mmHg (95%CI: 1.1-3.5) lower per 10 defined daily doses] and younger age [2.2 mmHg (95%CI: 0.3-4.2) higher per decade]. A larger proportion of the mixed ingestion group received intravenous fluids (OR 5.7, 95%CI: 1.8-18.6) and antidotes and/or vasopressors (OR 2.9, 95%CI: 1.004-8.6).

CONCLUSION

Combined overdoses of dihydropyridines with ARBs/ACEIs caused more significant hypotension and required more haemodynamic support than overdoses of dihydropyridines alone.

摘要

背景

氨氯地平,一种二氢吡啶钙通道阻滞剂(CCB),是导致美国心血管药物相关过量死亡的主要原因。相比之下,血管紧张素-II 受体阻滞剂(ARB)和血管紧张素转换酶抑制剂(ACEI)在过量服用时毒性最小。ACEI/ARB 通常与二氢吡啶类药物联合用于高血压治疗。同时摄入 ARB/ACEI 可能会显著增加二氢吡啶类药物的毒性,但这尚未得到研究。

目的

研究同时服用 ARB/ACEI 和单独服用二氢吡啶类药物的二氢吡啶类药物过量患者的临床结局。

方法

这是一项对澳大利亚新南威尔士毒物信息中心(NSW PIC)和 3 个毒理学单位(2016 年 1 月至 2019 年 6 月)报告的患者进行的回顾性研究。纳入年龄>14 岁、服用二氢吡啶类药物(氨氯地平、非洛地平、乐卡地平、硝苯地平)过量的患者。排除同时服用非二氢吡啶类 CCB、α-受体阻滞剂和β-受体阻滞剂的患者。收集患者的人口统计学、药物暴露详细信息、连续生命体征、治疗和结局。

结果

共纳入 100 例患者。68 例患者同时服用二氢吡啶类药物与 ARB/ACEI,32 例患者单独服用二氢吡啶类药物而未服用 ARB/ACEI。混合组的中位数最低平均动脉压更低(62 对 75mmHg,<0.001),更频繁地出现低血压(OR 4.5,95%CI:1.7-11.9)或心动过缓(OR 8.8,95%CI:1.1-70)。多变量分析表明,与单独组相比,混合组的最低收缩压(SBP)低 11.5mmHg(95%CI:4.9-18.1);与最低 SBP 较低相关的其他因素包括较高剂量[每 10 个定义日剂量低 2.3mmHg(95%CI:1.1-3.5)]和年龄较小[每 10 年高 2.2mmHg(95%CI:0.3-4.2)]。混合摄入组接受静脉补液(OR 5.7,95%CI:1.8-18.6)和解毒剂和/或血管加压药的比例更高(OR 2.9,95%CI:1.004-8.6)。

结论

与单独服用二氢吡啶类药物相比,同时服用二氢吡啶类药物与 ARB/ACEI 会导致更严重的低血压,并需要更多的血流动力学支持。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验